146 related articles for article (PubMed ID: 3307874)
1. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?
Butler J; Hoey BM
Br J Cancer Suppl; 1987 Jun; 8():53-9. PubMed ID: 3307874
[TBL] [Abstract][Full Text] [Related]
2. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Celli CM; Tran N; Knox R; Jaiswal AK
Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
[TBL] [Abstract][Full Text] [Related]
3. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
4. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
Powis G; Hodnett EM; Santone KS; See KL; Melder DC
Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
6. The reduction of anti-tumour diaziridinyl benzoquinones.
Butler J; Hoey BM; Lea JS
Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
[TBL] [Abstract][Full Text] [Related]
7. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
[TBL] [Abstract][Full Text] [Related]
8. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Friedman RD; Bachur NR
Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
Halinska A; Belej T; O'Brien PJ
Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
[TBL] [Abstract][Full Text] [Related]
10. Sonochemically induced covalent binding of calf thymus DNA by aziridinylquinones.
Alegria AE; Sanchez-Cruz P; Lopez-Colon D
Radiat Res; 2005 Oct; 164(4 Pt 1):446-52. PubMed ID: 16187747
[TBL] [Abstract][Full Text] [Related]
11. A comparison of free radical formation by quinone antitumour agents in MCF-7 cells and the role of NAD(P)H (quinone-acceptor) oxidoreductase (DT-diaphorase).
Fisher GR; Patterson LH; Gutierrez PL
Chem Biol Interact; 1993 Sep; 88(2-3):137-53. PubMed ID: 8403076
[TBL] [Abstract][Full Text] [Related]
12. Cytocidal action of the quinone group and its relationship to antitumor activity.
Begleiter A
Cancer Res; 1983 Feb; 43(2):481-4. PubMed ID: 6848172
[TBL] [Abstract][Full Text] [Related]
13. Free radical formation by antitumor quinones.
Powis G
Free Radic Biol Med; 1989; 6(1):63-101. PubMed ID: 2492250
[TBL] [Abstract][Full Text] [Related]
14. The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells.
Hasinoff BB; Begleiter A
Free Radic Res; 2006 Sep; 40(9):974-8. PubMed ID: 17015278
[TBL] [Abstract][Full Text] [Related]
15. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
Begleiter A; Blair GW
Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
Workman P
Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214
[TBL] [Abstract][Full Text] [Related]
17. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
[TBL] [Abstract][Full Text] [Related]
18. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
[TBL] [Abstract][Full Text] [Related]
19. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
20. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
Szmigiero L; Erickson LC; Ewig RA; Kohn KW
Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
